SARS-CoV-2 Nucleocapsid A2 (316-324) GMSRIGMEV
Order number: P4002.9501
Shipping: shipped at RT, store at -20°C Delivery time: 3- 8 working days
For detailed information on the delivery date, please contact Genaxxon.
| Quantity | Unit price |
|---|---|
| To 2 | €125.00 * |
| From 3 | €106.25 * |
Prices plus VAT plus shipping costs
SARS-CoV-2 Nucleocapsid A2 peptide GMSRIGMEV with amino acids 316-324 of the Nucleocapsid protein is an antigen-specific SARS-CoV-2 peptide.
Applications for SARS-CoV-2 peptides include, but are not limited to:
SARS-CoV-2 T cell stimulation
SARS-CoV-2 immune monitoring (Covid19 immune monitoring)
SARS-CoV-2 epitope discovery
SARS-CoV-2 target discovery
SARS-CoV-2 T cell assays
Technical Data:
Specifications:
Purity: >95% (HPLC)
Sequence: GMSRIGMEV
HLA-type: HLA-A*0201
lyophilized white powder
application:
SARS-CoV-2 T cell stimulation SARS-CoV-2 immune monitoring (Covid19 immune monitoring) SARS-CoV-2 epitope discovery SARS-CoV-2 target discovery SARS-CoV-2 T cell assaysSource
syntheticSicherheits Hinweise / Safety
Klassifizierungen / Classification
eclass-Nr: 34-16-04-90Dokumente - Protokolle - Downloads
Here you will find information and further literature on SARS-CoV-2 Nucleocapsid A2 (316-324) GMSRIGMEV. For further documents (certificates with additional lot numbers, safety data sheets in other languages, further product information) please contact Genaxxon biosience at: info@genaxxon.com or phone: +49 731 3608 123.